Paul Tudor Jones's GOSS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 5,995 shares of Gossamer Bio, Inc. (GOSS) worth $78,939, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in GOSS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 4,555 shares. Largest reduction occurred in Q4 2022, reducing 586 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Gossamer Bio (GOSS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gossamer Bio (GOSS) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +4,555 | Add 316.17% | 5,995 | $13.17 |
| Q1 2026 | +815 | Add 130.47% | 1,440 | $26.29 |
| Q4 2025 | -1 | Reduce 0.21% | 625 | $248.00 |
| Q3 2025 | +45 | Add 7.83% | 626 | $210.50 |
| Q1 2023 | +46,464 | New Buy | 581 | $0.10 |
| Q4 2022 | -586 | Sold Out | 0 | $0.00 |
| Q3 2022 | +46,867 | New Buy | 586 | $957.34 |
| Q2 2021 | -451 | Sold Out | 0 | $0.00 |
| Q1 2021 | +261 | Add 137.72% | 451 | $740.58 |
| Q4 2020 | +27 | Add 16.29% | 190 | $773.68 |
| Q3 2020 | +13,046 | New Buy | 163 | $993.87 |
Paul Tudor Jones's Gossamer Bio Investment FAQs
Paul Tudor Jones first purchased Gossamer Bio, Inc. (GOSS) in Q3 2020, acquiring 163 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Gossamer Bio, Inc. (GOSS) for 20 quarters since Q3 2020.
Paul Tudor Jones's largest addition to Gossamer Bio, Inc. (GOSS) was in Q3 2022, adding 586 shares worth $561,000.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 5,995 shares of Gossamer Bio, Inc. (GOSS), valued at approximately $78,939.
As of the Q2 2026 filing, Gossamer Bio, Inc. (GOSS) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Gossamer Bio, Inc. (GOSS) was 5,995 shares, as reported at the end of Q2 2026.